Logo image of LEN.B

LENNAR CORP - B SHS (LEN.B) Stock Fundamental Analysis

NYSE:LEN.B - New York Stock Exchange, Inc. - US5260573028 - Common Stock - Currency: USD

104.4  +0.41 (+0.39%)

Fundamental Rating

7

We assign a fundamental rating of 7 out of 10 to LEN.B. LEN.B was compared to 64 industry peers in the Household Durables industry. LEN.B gets an excellent profitability rating and is at the same time showing great financial health properties. LEN.B has a decent growth rate and is not valued too expensively. These ratings could make LEN.B a good candidate for quality investing.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year LEN.B was profitable.
LEN.B had a positive operating cash flow in the past year.
In the past 5 years LEN.B has always been profitable.
Each year in the past 5 years LEN.B had a positive operating cash flow.
LEN.B Yearly Net Income VS EBIT VS OCF VS FCFLEN.B Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

1.2 Ratios

LEN.B has a better Return On Assets (10.56%) than 82.81% of its industry peers.
The Return On Equity of LEN.B (16.26%) is better than 73.44% of its industry peers.
LEN.B has a Return On Invested Capital of 11.43%. This is in the better half of the industry: LEN.B outperforms 73.44% of its industry peers.
The Average Return On Invested Capital over the past 3 years for LEN.B is above the industry average of 10.33%.
Industry RankSector Rank
ROA 10.56%
ROE 16.26%
ROIC 11.43%
ROA(3y)10.45%
ROA(5y)10.53%
ROE(3y)15.85%
ROE(5y)16.42%
ROIC(3y)12.52%
ROIC(5y)11.96%
LEN.B Yearly ROA, ROE, ROICLEN.B Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

With an excellent Profit Margin value of 10.34%, LEN.B belongs to the best of the industry, outperforming 82.81% of the companies in the same industry.
LEN.B's Profit Margin has improved in the last couple of years.
With an excellent Operating Margin value of 13.74%, LEN.B belongs to the best of the industry, outperforming 82.81% of the companies in the same industry.
In the last couple of years the Operating Margin of LEN.B has grown nicely.
Looking at the Gross Margin, with a value of 15.21%, LEN.B is doing worse than 90.63% of the companies in the same industry.
In the last couple of years the Gross Margin of LEN.B has grown nicely.
Industry RankSector Rank
OM 13.74%
PM (TTM) 10.34%
GM 15.21%
OM growth 3Y-10.07%
OM growth 5Y2.56%
PM growth 3Y-12.02%
PM growth 5Y5.94%
GM growth 3Y-8.58%
GM growth 5Y3%
LEN.B Yearly Profit, Operating, Gross MarginsLEN.B Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

8

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), LEN.B is creating some value.
The number of shares outstanding for LEN.B has been reduced compared to 1 year ago.
Compared to 5 years ago, LEN.B has less shares outstanding
LEN.B has a better debt/assets ratio than last year.
LEN.B Yearly Shares OutstandingLEN.B Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
LEN.B Yearly Total Debt VS Total AssetsLEN.B Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

2.2 Solvency

LEN.B has an Altman-Z score of 4.23. This indicates that LEN.B is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of LEN.B (4.23) is better than 68.75% of its industry peers.
The Debt to FCF ratio of LEN.B is 2.27, which is a good value as it means it would take LEN.B, 2.27 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 2.27, LEN.B is in the better half of the industry, outperforming 73.44% of the companies in the same industry.
A Debt/Equity ratio of 0.16 indicates that LEN.B is not too dependend on debt financing.
The Debt to Equity ratio of LEN.B (0.16) is better than 70.31% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF 2.27
Altman-Z 4.23
ROIC/WACC1.21
WACC9.42%
LEN.B Yearly LT Debt VS Equity VS FCFLEN.B Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B 15B 20B 25B

2.3 Liquidity

A Current Ratio of 8.37 indicates that LEN.B has no problem at all paying its short term obligations.
LEN.B has a better Current ratio (8.37) than 87.50% of its industry peers.
LEN.B has a Quick Ratio of 1.84. This is a normal value and indicates that LEN.B is financially healthy and should not expect problems in meeting its short term obligations.
LEN.B has a better Quick ratio (1.84) than 79.69% of its industry peers.
Industry RankSector Rank
Current Ratio 8.37
Quick Ratio 1.84
LEN.B Yearly Current Assets VS Current LiabilitesLEN.B Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

5

3. Growth

3.1 Past

LEN.B shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -3.78%.
Measured over the past years, LEN.B shows a very strong growth in Earnings Per Share. The EPS has been growing by 20.01% on average per year.
Looking at the last year, LEN.B shows a small growth in Revenue. The Revenue has grown by 2.01% in the last year.
LEN.B shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.75% yearly.
EPS 1Y (TTM)-3.78%
EPS 3Y3.67%
EPS 5Y20.01%
EPS Q2Q%-23.74%
Revenue 1Y (TTM)2.01%
Revenue growth 3Y9.32%
Revenue growth 5Y9.75%
Sales Q2Q%4.36%

3.2 Future

Based on estimates for the next years, LEN.B will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.19% on average per year.
Based on estimates for the next years, LEN.B will show a small growth in Revenue. The Revenue will grow by 5.79% on average per year.
EPS Next Y-27.99%
EPS Next 2Y-8.17%
EPS Next 3Y2.27%
EPS Next 5Y10.19%
Revenue Next Year0.9%
Revenue Next 2Y2.61%
Revenue Next 3Y4.43%
Revenue Next 5Y5.79%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
LEN.B Yearly Revenue VS EstimatesLEN.B Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 10B 20B 30B 40B 50B
LEN.B Yearly EPS VS EstimatesLEN.B Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5 10 15 20 25

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 7.60, the valuation of LEN.B can be described as very cheap.
Compared to the rest of the industry, the Price/Earnings ratio of LEN.B indicates a somewhat cheap valuation: LEN.B is cheaper than 68.75% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 26.32. LEN.B is valued rather cheaply when compared to this.
A Price/Forward Earnings ratio of 8.63 indicates a reasonable valuation of LEN.B.
LEN.B's Price/Forward Earnings ratio is in line with the industry average.
LEN.B is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.13, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 7.6
Fwd PE 8.63
LEN.B Price Earnings VS Forward Price EarningsLEN.B Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

LEN.B's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. LEN.B is cheaper than 81.25% of the companies in the same industry.
64.06% of the companies in the same industry are more expensive than LEN.B, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 17.3
EV/EBITDA 5.67
LEN.B Per share dataLEN.B EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

The excellent profitability rating of LEN.B may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.38
EPS Next 2Y-8.17%
EPS Next 3Y2.27%

6

5. Dividend

5.1 Amount

LEN.B has a Yearly Dividend Yield of 1.78%.
Compared to an average industry Dividend Yield of 3.54, LEN.B pays a bit more dividend than its industry peers.
Compared to the average S&P500 Dividend Yield of 2.40, LEN.B is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.78%

5.2 History

On average, the dividend of LEN.B grows each year by 65.54%, which is quite nice.
LEN.B has been paying a dividend for at least 10 years, so it has a reliable track record.
LEN.B has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)65.54%
Div Incr Years1
Div Non Decr Years15
LEN.B Yearly Dividends per shareLEN.B Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

LEN.B pays out 14.64% of its income as dividend. This is a sustainable payout ratio.
LEN.B's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP14.64%
EPS Next 2Y-8.17%
EPS Next 3Y2.27%
LEN.B Yearly Income VS Free CF VS DividendLEN.B Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B 5B
LEN.B Dividend Payout.LEN.B Dividend Payout, showing the Payout Ratio.LEN.B Dividend Payout.PayoutRetained Earnings

LENNAR CORP - B SHS

NYSE:LEN.B (6/16/2025, 1:02:20 PM)

104.4

+0.41 (+0.39%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)03-20 2025-03-20/amc
Earnings (Next)06-16 2025-06-16/amc
Inst Owners96.74%
Inst Owner Change-0.95%
Ins Owners1.76%
Ins Owner ChangeN/A
Market Cap27.54B
Analysts70
Price Target138.4 (32.57%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.78%
Yearly Dividend2
Dividend Growth(5Y)65.54%
DP14.64%
Div Incr Years1
Div Non Decr Years15
Ex-Date04-23 2025-04-23 (0.5)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)4.28%
Min EPS beat(2)-3.31%
Max EPS beat(2)11.86%
EPS beat(4)3
Avg EPS beat(4)7.52%
Min EPS beat(4)-3.31%
Max EPS beat(4)16.11%
EPS beat(8)7
Avg EPS beat(8)10.85%
EPS beat(12)10
Avg EPS beat(12)10.69%
EPS beat(16)12
Avg EPS beat(16)7.75%
Revenue beat(2)1
Avg Revenue beat(2)-0.33%
Min Revenue beat(2)-2.32%
Max Revenue beat(2)1.66%
Revenue beat(4)3
Avg Revenue beat(4)0.71%
Min Revenue beat(4)-2.32%
Max Revenue beat(4)1.88%
Revenue beat(8)6
Avg Revenue beat(8)2.52%
Revenue beat(12)8
Avg Revenue beat(12)2.42%
Revenue beat(16)12
Avg Revenue beat(16)2.39%
PT rev (1m)1.15%
PT rev (3m)-8.86%
EPS NQ rev (1m)-0.67%
EPS NQ rev (3m)-27.42%
EPS NY rev (1m)0%
EPS NY rev (3m)-17.11%
Revenue NQ rev (1m)-0.37%
Revenue NQ rev (3m)-6.16%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.69%
Valuation
Industry RankSector Rank
PE 7.6
Fwd PE 8.63
P/S 0.77
P/FCF 17.3
P/OCF 15.77
P/B 1.21
P/tB 1.44
EV/EBITDA 5.67
EPS(TTM)13.73
EY13.15%
EPS(NY)12.09
Fwd EY11.58%
FCF(TTM)6.03
FCFY5.78%
OCF(TTM)6.62
OCFY6.34%
SpS135.56
BVpS86.16
TBVpS72.39
PEG (NY)N/A
PEG (5Y)0.38
Profitability
Industry RankSector Rank
ROA 10.56%
ROE 16.26%
ROCE 14.98%
ROIC 11.43%
ROICexc 12.38%
ROICexgc 18.99%
OM 13.74%
PM (TTM) 10.34%
GM 15.21%
FCFM 4.45%
ROA(3y)10.45%
ROA(5y)10.53%
ROE(3y)15.85%
ROE(5y)16.42%
ROIC(3y)12.52%
ROIC(5y)11.96%
ROICexc(3y)14.71%
ROICexc(5y)13.75%
ROICexgc(3y)18.6%
ROICexgc(5y)16.93%
ROCE(3y)16.4%
ROCE(5y)15.67%
ROICexcg growth 3Y-0.73%
ROICexcg growth 5Y10.92%
ROICexc growth 3Y-5.57%
ROICexc growth 5Y8.18%
OM growth 3Y-10.07%
OM growth 5Y2.56%
PM growth 3Y-12.02%
PM growth 5Y5.94%
GM growth 3Y-8.58%
GM growth 5Y3%
F-Score6
Asset Turnover1.02
Health
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF 2.27
Debt/EBITDA 0.72
Cap/Depr 129.15%
Cap/Sales 0.43%
Interest Coverage 250
Cash Conversion 34.71%
Profit Quality 43.07%
Current Ratio 8.37
Quick Ratio 1.84
Altman-Z 4.23
F-Score6
WACC9.42%
ROIC/WACC1.21
Cap/Depr(3y)101.58%
Cap/Depr(5y)91.5%
Cap/Sales(3y)0.32%
Cap/Sales(5y)0.3%
Profit Quality(3y)86.08%
Profit Quality(5y)96.72%
High Growth Momentum
Growth
EPS 1Y (TTM)-3.78%
EPS 3Y3.67%
EPS 5Y20.01%
EPS Q2Q%-23.74%
EPS Next Y-27.99%
EPS Next 2Y-8.17%
EPS Next 3Y2.27%
EPS Next 5Y10.19%
Revenue 1Y (TTM)2.01%
Revenue growth 3Y9.32%
Revenue growth 5Y9.75%
Sales Q2Q%4.36%
Revenue Next Year0.9%
Revenue Next 2Y2.61%
Revenue Next 3Y4.43%
Revenue Next 5Y5.79%
EBIT growth 1Y-14.59%
EBIT growth 3Y-1.69%
EBIT growth 5Y12.56%
EBIT Next Year-25.6%
EBIT Next 3Y-0.73%
EBIT Next 5Y5.08%
FCF growth 1Y-62.63%
FCF growth 3Y-3.29%
FCF growth 5Y9.84%
OCF growth 1Y-59.54%
OCF growth 3Y-1.73%
OCF growth 5Y10.15%